Luliconazole cream 30 gm in packs of 45 piece represents a focused approach to topical antifungal supply for clinics and retail pharmacies. This format delivers a precise, ready to use option for managing common superficial fungal infections.
Each tube contains 30 grams of luliconazole, a potent azole agent that disrupts fungal cell membrane synthesis. The 45 piece configuration is designed to support consistent inventory control and reliable patient access in both hospital and community settings.
| Product Name | Strength | Pack Size | Packaging Type | Typical Use Setting |
|---|---|---|---|---|
| Luliconazole Cream | 30 gm per tube | 45 Piece | Individually sealed tubes | Pharmacy and clinical dispensing |
| Unit Type | Topical antifungal | Gross quantity | Tamper evident carton | Retail and institutional supply |
| Storage Condition | Room temperature | Shelf Life | Batch traceability | Regulatory compliance |
Understanding Luliconazole 30 gm Formulation
Luliconazole acts by inhibiting fungal lanosterol demethylase, reducing membrane ergosterol production. This mechanism is critical for broad activity against dermatophytes, molds, and certain yeasts responsible for superficial infections.
The 30 gm tube size balances patient needs with dosing economy, ensuring sufficient volume for standard treatment courses on localized areas. This size is particularly suitable for once daily regimens, improving adherence and clinical outcomes.
Clinical Applications and Indications
Tinea Pedis and Corporis Management
Clinicians prescribe luliconazole cream for tinea pedis and tinea corporis due to its rapid absorption and low systemic bioavailability. Patients typically experience symptomatic relief with consistent twice daily application for the recommended duration.
Interdigital and Moccasin Type Infections
Interdigital maceration and moccasin type tinea pedis respond well to luliconazole because the formulation stays in place and provides sustained antifungal action at the site of infection. This reduces recurrence risk when patients adhere to therapy.
Manufacturing Quality and Regulatory Aspects
Manufacturers of luliconazole cream 30 gm follow strict Good Manufacturing Practices to ensure batch uniformity, sterility, and accurate labeling. Quality control tests include assay determination, dissolution, and microbial limits verification.
Regulatory agencies require stability studies under various temperature and humidity conditions to establish appropriate shelf life. Packaging materials are selected to protect the active ingredient from light, moisture, and mechanical stress during transport.
Stock Management for 45 Piece Packs
Health system procurement teams favor the 45 piece pharmaceutical cream gels format for its logistical efficiency. Standardized packaging simplifies receiving, storage, and expiration tracking compared to mixed case configurations.
Automated dispensing systems can be calibrated to recognize individual tube dimensions, reducing dispensing errors. Centralized inventory platforms further enhance visibility and support just in time replenishment strategies.
Operational Recommendations for Clinics
- Implement first in first out rotation to minimize expired stock
- Train staff on proper tube handling and storage conditions
- Integrate barcode scanning for accurate dispensing and inventory tracking
- Document lot numbers and expiration dates in patient medication records
- Establish reorder points based on consumption patterns for the 45 piece format
FAQ
Reader questions
How should luliconazole cream 30 gm be stored in a clinic pharmacy?
Store at controlled room temperature, away from excessive heat, moisture, and direct light. Keep tubes in their carton until use to maintain labeling integrity and prevent accidental damage.
What are the signs that a tube should not be used?
Discard if the tube seal is broken, the product shows discoloration, unusual odor, or texture changes. Patients should also stop use and consult their healthcare provider if irritation or new symptoms appear after application.
Can this product be used on pediatric patients?
Pediatric use requires careful risk benefit assessment and precise weight based dosing. Prescribers should follow local guidelines, monitor for local skin reactions, and consider the patient’s ability to adhere to the application schedule.
Is systemic absorption a concern with widespread application?
Systemic absorption of luliconazole from intact skin is minimal even with repeated dosing. Nonetheless, clinicians should avoid use on large body surface areas or on compromised skin unless the potential benefit clearly outweighs theoretical risks.